Clinical Trial Update: Neuroendocrine and Adrenal Tumors

View source ↗

Summary

The clinical trial NCT04432532 investigating neuroendocrine tumors and adrenal tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Tumor
• Neuroendocrine Tumor

Snippet

Sponsor: University of Pennsylvania | Conditions: Neuroendocrine Tumors, Adrenal Tumor | Status: WITHDRAWN